Nanhai Zhang

Dr. Nanhai Zhang

China Agricultural University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
Liang ZhaoLiang Zhao
Liang Zhao
NZNanhai Zhang
Nanhai Zhang
Dong YangDong Yang
Dong Yang
MYMengyan Yang
Mengyan Yang
XGXiaoxuan Guo
Xiaoxuan Guo
FZFeng Zhou
Feng Zhou
Alcoholic liver disease (ALD) has become one of the major global health problems, with augmented morbidity and mortality. Evidence indicates that flavonoids can reduce the risk of ALD owing to their biological properties. However, the effect of structurally different flavonoid subclasses on alleviating alcohol-induced liver damage in a same model has never been studied. In this study, mice were supplemented with five kinds of flavonoid subgroups, apigenin (flavone), quercetin (flavonol), naringenin (flavanone), (-)-epigallocatechin gallate (flavanol), and genistein (isoflavone), in the same dose (0.3 mmol kg−1 body weight) and then given 50% alcohol by gastric perfusion for five consecutive weeks. The results demonstrated that genistein and naringenin had greater benefits in terms of mitigating fibrosis and apoptosis, respectively, in the liver. Lipid deposition, partial inflammatory-related factors (nuclear factor kappa B p65, cyclooxygenase-2, and interleukin-6 levels), and hepatic histopathological alterations were similarly attenuated by five kinds of flavonoids. All the flavonoids also showed different degrees of influence on protecting against alcoholic liver injury on other aspects, such as serum biochemistry makers, hepatic lipid accumulation, lipid peroxidation, antioxidant capacities, and inflammation.

3 November 2021 in Foods
Verified
Journal Article
Open access
PDF file
JZJingxuan Zhou
Jingxuan Zhou
NZNanhai Zhang
Nanhai Zhang
Liang ZhaoLiang Zhao
Liang Zhao
WWWei Wu
Wei Wu
LZLiebing Zhang
Liebing Zhang
JLJingming Li
Jingming Li
Astragalus, a medical and edible plant in China, shows several bioactive properties. However, the role of astragalus in attenuating alcoholic liver disease (ALD) is less clear. The objective of this project is to investigate the improving effect of astragalus saponins (AS) and astragalus polysaccharides (AP), which are the two primary constituents in astragalus on hepatic injury induced by alcohol, and the potential mechanisms of action. Different doses of AS (50 and 100 mg/kg bw) and AP (300 and 600 mg/kg bw) were orally given to alcohol-treated mice for four weeks. The results demonstrated that both AP and AS could reverse the increase of the levels of TC, TG, FFA, and LDL-C in serum, and the decrease of serum HDL-C content, as well as the elevation of hepatic TC and TG levels induced by alcohol. The activities of AST, ALT, ALP, and γ-GT in ALD mice were raised after AP and AS supplementation. The antioxidant markers (SOD, CAT, GSH, and GSH-Px) were obviously augmented and the pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) and hepatic histological variations were alleviated by AP and AS, which was in line with the levels of oxidative stress-associated genes (Keap1, Nfe2l2, Nqo1, and Hmox1) and inflammation-associated genes (Tlr4, Myd88 and Nfkb1). In addition, AS exerted a more efficient effect than AP and the results presented dose proportionality. Moreover, AS and AP could modulate the intestinal microbiota disturbance induced by alcohol. Overall, AS and AP administration could ameliorate lipid accumulation in the serum and liver, as well as hepatic function, oxidative stress, inflammatory response, and gut flora disorders in mice as a result of alcohol.

2 November 2021 in Foods
Verified
Journal Article
Open access
PDF file
PSPeng Sun
Peng Sun
Liang ZhaoLiang Zhao
Liang Zhao
NZNanhai Zhang
Nanhai Zhang
JZJingxuan Zhou
Jingxuan Zhou
LZLiebing Zhang
Liebing Zhang
FZFeng Zhou
Feng Zhou
Cardiovascular diseases are the leading causes of the death around the world. An elevation of the low-density lipoprotein cholesterol (LDL-C) level is one of the most important risk factors for cardiovascular diseases. To achieve optimal plasma LDL-C levels, clinal therapies were investigated which targeted different metabolism pathways. However, some therapies also caused various adverse effects. Thus, there is a need for new treatment options and/or combination therapies to inhibit the LDL-C level. Dietary polyphenols have received much attention in the prevention of cardiovascular diseases due to their potential LDL-C lowering effects. However, the effectiveness and potential mechanisms of polyphenols in lowering LDL-C is not comprehensively summarized. This review focused on dietary polyphenols that could reduce LDL-C and their mechanisms of action. This review also discussed the limitations and suggestions regarding previous studies.

20 August 2025 in Foods
Verified
Journal Article
Open access
PDF file
HJHedong Jiang
Hedong Jiang
NZNanhai Zhang
Nanhai Zhang
Liuming XieLiuming Xie
Liuming Xie
GLGonglong Li
Gonglong Li
LCLihua Chen
Lihua Chen
ZLZhenggen Liao
Zhenggen Liao
Instant powder, with its high formulation flexibility, ease of quantification, long shelf life, and convenient storage and transportation, holds a significant position in the modern food industry and has experienced rapid development. However, most powder products not optimized for instant use often encounter issues such as surface floating and clumping during rehydration. Some products remain unevenly distributed even after stirring or extending the settling time, severely impacting consumer experience. This paper systematically reviews the key factors influencing the rehydration performance of instant powders, including chemical composition, particle microstructure, and processing techniques. It also delves into corresponding improvement strategies, such as particle structure design, particle modification, and the optimization of rehydration methods. This paper aims to provide theoretical references and practical guidance for technological innovation and product development in the field of instant powders.

17 January 2023 in Food & Function
Verified
Journal Article
Closed access
PDF file
NZNanhai Zhang
Nanhai Zhang
JZJingxuan Zhou
Jingxuan Zhou
LZLiang Zhao
Liang Zhao
ZZZhen Zhao
Zhen Zhao
SWShiran Wang
Shiran Wang
FZFeng Zhou
Feng Zhou
The prevalence of hyperuricemia (HUA) has been rising, and it is typically accompanied by renal injury and intestinal flora disorder, leading to a non-negligible health crisis. Ferulic acid (FA), as a familiar polyphenol, has been proven to exert anti-hyperuricemic properties via inhibiting uric acid (UA) synthesis; however, the detailed underlying mechanisms remain unclear. The aim of this study was to explore the regulatory effect of FA on UA excretion as a potential strategy for reducing UA levels, and the comorbidities of HUA. FA treatment downregulated the expression of urate absorption transporter genes and repressed the toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) pathway in UA-stimulated HK-2 cells. To examine these effects in vivo, FA or allopurinol (positive control) was given to rats with HUA induced by a high-fructose/fat diet (HFFD) for 20 weeks. FA markedly decreased the serum UA, blood urea nitrogen, and creatinine levels. The expression of urate absorption transporters was downregulated, whereas the expression of secretion transporters was upregulated in the kidneys and intestines of FA-treated HUA rats. Additionally, FA mitigated renal oxidative stress, and suppressed the activation of the TLR4/NF-κB pathway and the downstream inflammatory response-related markers in the kidneys. Moreover, FA remodeled the composition of the gut microbiota, characterized by an increase in beneficial bacteria (e.g., Lactobacillus and Ruminococcus) and a decrease in pathogenic bacteria (e.g., Bacteroides). In conclusion, our study validated FA as an effective nutrient to ameliorate HFFD-induced HUA, suggesting its potential to mitigate the HUA-associated renal impairment and intestinal microbiota disturbance.

20 June 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Liang ZhaoLiang Zhao
Liang Zhao
SWShaoxuan Wang
Shaoxuan Wang
NZNanhai Zhang
Nanhai Zhang
JZJingxuan Zhou
Jingxuan Zhou
AMArshad Mehmood
Arshad Mehmood
Zhao LeiZhao Lei
Zhao Lei
Alcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. It can cause fatty liver (steatosis), steatohepatitis, fibrosis, cirrhosis, and liver cancer. Alcohol consumption can also disturb the composition of gut microbiota, increasing the composition of harmful microbes and decreasing beneficial ones. Restoring eubiosis or preventing dysbiosis after alcohol consumption is an important strategy in treating ALD. Plant natural products and polyphenolic compounds exert beneficial effects on several metabolic disorders associated with ALD. Natural products and related phytochemicals act through multiple pathways, such as modulating gut microbiota, improving redox stress, and anti-inflammation. In the present review article, we gather information on natural extract and bioactive compounds on the gut-liver axis for the possible treatment of ALD. Supplementation with natural extracts and bioactive compounds promoted the intestinal tight junction, protected against the alcohol-induced gut leakiness and inflammation, and reduced endotoxemia in alcohol-exposed animals. Taken together, natural extracts and bioactive compounds have strong potential against ALD; however, further clinical studies are still needed.